Global and Widespread Local White Matter Abnormalities in Juvenile Neuronal Ceroid Lipofuscinosis

References

1. 1.↵
   2. Santavuori P,
   3. Lauronen L,
   4. Kirveskari K, et al

   . Neuronal ceroid lipofuscinoses in childhood. Suppl Clin Neurophysiol 2000;53:443–51 doi:10.1016/S1567-424X(09)70193-X pmid:12741032

   CrossRefPubMed
2. 2.↵
   2. Collins J,
   3. Holder GE,
   4. Herbert H, et al

   . Batten disease: features to facilitate early diagnosis. Br J Ophthalmol 2006;90:1119–24 doi:10.1136/bjo.2006.091637 pmid:16754648

   Abstract/FREE Full Text
3. 3.↵
   2. Spalton DJ,
   3. Taylor DS,
   4. Sanders MD

   . Juvenile Batten's disease: an ophthalmological assessment of 26 patients. Br J Ophthalmol 1980;64:726–32 doi:10.1136/bjo.64.10.726 pmid:7426545

   Abstract/FREE Full Text
4. 4.↵
   2. Järvelä I,
   3. Autti T,
   4. Lamminranta S, et al

   . Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 1997;42:799–802 doi:10.1002/ana.410420517 pmid:9392580

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Santavuori P,
   3. Linnankivi T,
   4. Jaeken J, et al

   . Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL). J Inherit Metab Dis 1993;16:245–48 doi:10.1007/BF00710255 pmid:8411971

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Jalanko A,
   3. Braulke T

   . Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 2009;1793:697–709 doi:10.1016/j.bbamcr.2008.11.004 pmid:19084560

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Miller JN,
   3. Chan CH,
   4. Pearce DA

   . The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis. Hum Mol Genet 2013;22:2723–34 doi:10.1093/hmg/ddt120 pmid:23539563

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Kousi M,
   3. Lehesjoki AE,
   4. Mole SE

   . Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 2012;33:42–63 doi:10.1002/humu.21624 pmid:21990111

   CrossRefPubMed
9. 9.↵
   2. Uvebrant P,
   3. Hagberg B

   . Neuronal ceroid lipofuscinoses in Scandinavia: epidemiology and clinical pictures. Neuropediatrics 1997;28:6–8 doi:10.1055/s-2007-973654 pmid:9151309

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Claussen M,
    3. Heim P,
    4. Knispel J, et al

    . Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet 1992;42:536–38 doi:10.1002/ajmg.1320420422 pmid:1609834

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Cardona F,
    3. Rosati E

    . Neuronal ceroid-lipofuscinoses in Italy: an epidemiological study. Am J Med Genet 1995;57:142–43 doi:10.1002/ajmg.1320570206 pmid:7668318

    CrossRefPubMedWeb of Science
12. 12.↵
    2. MacLeod PM,
    3. Dolman CL,
    4. Chang E, et al

    . The neuronal ceroid lipofuscinoses in British Columbia: a clinical epidemiologic and ultrastructural study. Birth Defects Orig Artic Ser 1976;12:289–96 pmid:974252

    PubMed
13. 13.↵
    2. Lerner TJ,
    3. Boustany RM,
    4. Anderson JW, et al

    . Isolation of a novel gene underlying Batten disease, CLN3: the International Batten Disease Consortium. Cell 1995;82:949–57 doi:10.1016/0092-8674(95)90274-0 pmid:7553855

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Williams RE,
    3. Aberg L,
    4. Autti T, et al

    . Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim Biophys Acta 2006;1762:865–72 doi:10.1016/j.bbadis.2006.07.001 pmid:16930952

    CrossRefPubMed
15. 15.↵
    2. Autti T,
    3. Raininko R,
    4. Vanhanen SL, et al

    . MRI of neuronal ceroid lipofuscinosis, I: cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology 1996;38:476–82 doi:10.1007/BF00607283 pmid:8837098

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Tokola AM,
    3. Salli EK,
    4. Åberg LE, et al

    . Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study. Pediatr Neurol 2014;50:158–63 doi:10.1016/j.pediatrneurol.2013.10.013 pmid:24411222

    CrossRefPubMed
17. 17.↵
    2. Autti T,
    3. Hämäläinen J,
    4. Åberg L, et al

    . Thalami and corona radiata in juvenile NCL (CLN3): a voxel-based morphometric study. Eur J Neurol 2007;14:447–50 doi:10.1111/j.1468-1331.2007.01692.x pmid:17388996

    CrossRefPubMed
18. 18.↵
    2. Autti T,
    3. Raininko R,
    4. Santavuori P, et al

    . MRI of neuronal ceroid lipofuscinosis, II: postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. Neuroradiology 1997;39:371–77 doi:10.1007/s002340050427 pmid:9189886

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Autti T,
    3. Joensuu R,
    4. Aberg L

    . Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 2007;49:571–78 doi:10.1007/s00234-007-0220-6 pmid:17334752

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Jadav RH,
    3. Sinha S,
    4. Yasha TC, et al

    . Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes. Pediatr Neurol 2014;50:85–95 doi:10.1016/j.pediatrneurol.2013.08.008 pmid:24120650

    CrossRefPubMed
21. 21.↵
    2. Basser PJ,
    3. Mattiello J,
    4. LeBihan D

    . MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–67 doi:10.1016/S0006-3495(94)80775-1 pmid:8130344

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Basser PJ,
    3. Mattiello J,
    4. LeBihan D

    . Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247–54 doi:10.1006/jmrb.1994.1037 pmid:8019776

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Beaulieu C

    . The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002;15:435–55 doi:10.1002/nbm.782 pmid:12489094

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Dyke JP,
    3. Voss HU,
    4. Sondhi D, et al

    . Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging. AJNR Am J Neuroradiol 2007;28:1232–36 doi:10.3174/ajnr.A0551 pmid:17698521

    Abstract/FREE Full Text
25. 25.↵
    2. Jeurissen B,
    3. Leemans A,
    4. Jones DK, et al

    . Probabilistic fiber tracking using the residual bootstrap with constrained spherical deconvolution. Hum Brain Mapp 2011;32:461–79 doi:10.1002/hbm.21032 pmid:21319270

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Johansen-Berg H, et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505 doi:10.1016/j.neuroimage.2006.02.024 pmid:16624579

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Basser PJ,
    3. Pajevic S,
    4. Pierpaoli C, et al

    . In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000;44:625–32 pmid:11025519

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Mori S,
    3. van Zijl PC

    . Fiber tracking: principles and strategies—a technical review. NMR Biomed 2002;15:468–80 doi:10.1002/nbm.781 pmid:12489096

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Vos SB,
    3. Jones DK,
    4. Viergever MA, et al

    . Partial volume effect as a hidden covariate in DTI analyses. Neuroimage 2011;55:1566–76 doi:10.1016/j.neuroimage.2011.01.048 pmid:21262366

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Tournier JD,
    3. Mori S,
    4. Leemans A

    . Diffusion tensor imaging and beyond. Magn Reson Med 2011;65:1532–56 doi:10.1002/mrm.22924 pmid:21469191

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Tournier JD,
    3. Calamante F,
    4. Gadian DG, et al

    . Direct estimation of the fiber orientation density function from diffusion-weighted MRI data using spherical deconvolution. Neuroimage 2004;23:1176–85 doi:10.1016/j.neuroimage.2004.07.037 pmid:15528117

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Tournier JD,
    3. Calamante F,
    4. Connelly A

    . Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage 2007;35:1459–72 doi:10.1016/j.neuroimage.2007.02.016 pmid:17379540

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Tournier JD,
    3. Yeh CH,
    4. Calamante F, et al

    . Resolving crossing fibres using constrained spherical deconvolution: validation using diffusion-weighted imaging phantom data. Neuroimage 2008;42:617–25 doi:10.1016/j.neuroimage.2008.05.002 pmid:18583153

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Kristo G,
    3. Leemans A,
    4. Raemaekers M, et al

    . Reliability of two clinically relevant fiber pathways reconstructed with constrained spherical deconvolution. Magn Reson Med 2013;70:1544–56 doi:10.1002/mrm.24602 pmid:23359402

    CrossRefPubMed
35. 35.↵
    2. Farquharson S,
    3. Tournier JD,
    4. Calamante F, et al

    . White matter fiber tractography: why we need to move beyond DTI. J Neurosurg 2013;118:1367–77 doi:10.3171/2013.2.JNS121294 pmid:23540269

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Jeurissen B,
    3. Leemans A,
    4. Tournier JD, et al

    . Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum Brain Mapp 2013;34:2747–66 doi:10.1002/hbm.22099 pmid:22611035

    CrossRefPubMed
37. 37.↵
    Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738–50 doi:10.1002/mds.10473 pmid:12815652

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Toiviainen-Salo S,
    3. Mäkitie O,
    4. Mannerkoski M, et al

    . Shwachman-Diamond syndrome is associated with structural brain alterations on MRI. Am J Med Genet A 2008;146A:1558–64 doi:10.1002/ajmg.a.32354 pmid:18478597

    CrossRefPubMed
39. 39.↵
    2. Leemans A,
    3. Jeurissen B,
    4. Sijbers J, et al

    . ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. In: Proceedings of the Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii. April 18–24, 2009;17:3537
40. 40.↵
    2. Leemans A,
    3. Jones DK

    . The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009;61:1336–49 doi:10.1002/mrm.21890 pmid:19319973

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Irfanoglu MO,
    3. Walker L,
    4. Sarlls J, et al

    . Effects of image distortions originating from susceptibility variations and concomitant fields on diffusion MRI tractography results. Neuroimage 2012;61:275–88 doi:10.1016/j.neuroimage.2012.02.054 pmid:22401760

    CrossRefPubMed
42. 42.↵
    2. Westin CF,
    3. Maier SE,
    4. Mamata H, et al

    . Processing and visualization for diffusion tensor MRI. Med Image Anal 2002;6:93–108 doi:10.1016/S1361-8415(02)00053-1 pmid:12044998

    CrossRefPubMedWeb of Science
43. 43.↵
    2. Vos SB,
    3. Jones DK,
    4. Jeurissen B, et al

    . The influence of complex white matter architecture on the mean diffusivity in diffusion tensor MRI of the human brain. Neuroimage 2012;59:2208–16 doi:10.1016/j.neuroimage.2011.09.086 pmid:22005591

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Wiegell MR,
    3. Larsson HB,
    4. Wedeen VJ

    . Fiber crossing in human brain depicted with diffusion tensor MR imaging. Radiology 2000;217:897–903 doi:10.1148/radiology.217.3.r00nv43897 pmid:11110960

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Ennis DB,
    3. Kindlmann G

    . Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 2006;55:136–46 doi:10.1002/mrm.20741 pmid:16342267

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl 1):S208–19 doi:10.1016/j.neuroimage.2004.07.051 pmid:15501092

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Andersson JL,
    3. Sotiropoulos SN

    . Non-parametric representation and prediction of single- and multi-shell diffusion-weighted MRI data using Gaussian processes. Neuroimage 2015;122:166–76 doi:10.1016/j.neuroimage.2015.07.067 pmid:26236030

    CrossRefPubMed
48. 48.↵
    2. Winkler AM,
    3. Ridgway GR,
    4. Webster MA, et al

    . Permutation inference for the general linear model. Neuroimage 2014;92:381–97 doi:10.1016/j.neuroimage.2014.01.060 pmid:24530839

    CrossRefPubMed
49. 49.↵
    2. Paniagua Bravo A,
    3. Forkert ND,
    4. Schulz A, et al

    . Quantitative T2 measurements in juvenile and late infantile neuronal ceroid lipofuscinosis. Clin Neuroradiol 2013;23:189–96 doi:10.1007/s00062-012-0189-3 pmid:23263384

    CrossRefPubMed
50. 50.↵
    2. Tournier JD,
    3. Calamante F,
    4. Connelly A

    . Determination of the appropriate b value and number of gradient directions for high-angular-resolution diffusion-weighted imaging. NMR Biomed 2013;26:1775–86 doi:10.1002/nbm.3017 pmid:24038308

    CrossRefPubMedWeb of Science
51. 51.↵
    2. Toselli B,
    3. Tortora D,
    4. Severino M, et al

    . Improvement in white matter tract reconstruction with constrained spherical deconvolution and track density mapping in low angular resolution data: a pediatric study and literature review. Front Pediatr 2017;5:182 doi:10.3389/fped.2017.00182 pmid:28913326

    CrossRefPubMed
52. 52.↵
    2. Bach M,
    3. Laun FB,
    4. Leemans A, et al

    . Methodological considerations on tract-based spatial statistics (TBSS). Neuroimage 2014;100:358–69 doi:10.1016/j.neuroimage.2014.06.021 pmid:24945661

    CrossRefPubMed